ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
62 hedge funds and large institutions have $8.05M invested in Zynerba Pharmaceuticals, Inc in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
69% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 26
Holders
62
Holding in Top 10
–
Calls
$351K
Puts
$843K
Top Buyers
| 1 | +$825K | |
| 2 | +$547K | |
| 3 | +$427K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$297K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$159K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.14M | |
| 3 | -$367K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$352K |
| 5 |
CCA
Cruiser Capital Advisors
Stamford,
Connecticut
|
-$301K |